Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
iX Syrinx Pty Ltd is a Pharmaceutical Manufacturing brand in Melbourne, Victoria. It is publicly held, and its site is ixsyrinx.com. It holds one address on record, all in Australia. Headcount on record is 19. One Australian registration (ABN) is a confirmed match. It is listed alongside nine similar brands, mostly in Pharmaceutical Manufacturing.
ABN20149728825
| IX SYRINX PTY LTD | ABN 20149728825 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
iX Syrinx is an expanding global company, who is dedicated to improving health outcomes for our clients with our range of pharmaceutical and nutraceutical products.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: IX SYRINX PTY LTD (ABN 20 149 728 825), high confidence.
19 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: Merrindale Dr, Melbourne, Victoria 3136.
None linked to this brand.
7 profiles list iX Syrinx Pty Ltd as a peer — 79th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. PharmaGreen Consulting Pty Ltd and HL Pharma list it back.